Healthcare provider profile · identity verified

Yulkania Serrano Falcon

General Practice · HIALEAH, FL · NPI 1760138549

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	594	196
Losartan Potassium	Losartan Potassium	517	156
Famotidine	Famotidine	479	154
Rosuvastatin Calcium	Rosuvastatin Calcium	405	135
Metformin Hcl	Metformin Hcl	383	114
Gabapentin	Gabapentin	374	127
Levothyroxine Sodium	Levothyroxine Sodium	292	82
Furosemide	Furosemide	289	87
Metoprolol Succinate	Metoprolol Succinate	261	84
Fluticasone Propionate	Fluticasone Propionate	253	79
Alcohol Prep Pads	Alcohol Antiseptic Pads	239	62
Farxiga	Dapagliflozin Propanediol	237	35
Omeprazole	Omeprazole	229	75
Ozempic	Semaglutide	221	33
Amlodipine Besylate	Amlodipine Besylate	220	73
Levocetirizine Dihydrochloride	Levocetirizine Dihydrochloride	220	74
Baclofen	Baclofen	217	80
Albuterol Sulfate Hfa	Albuterol Sulfate	211	53
Azelastine Hcl	Azelastine Hcl	210	57
Lisinopril	Lisinopril	208	65
Trulicity	Dulaglutide	204	29
Vascepa	Icosapent Ethyl	201	39
Vitamin D2	Ergocalciferol (Vitamin D2)	189	85
Hydrochlorothiazide	Hydrochlorothiazide	175	58
Eliquis	Apixaban	162	35
Clonidine Hcl	Clonidine Hcl	150	33
Clopidogrel	Clopidogrel Bisulfate	148	46
Pantoprazole Sodium	Pantoprazole Sodium	138	46
Ammonium Lactate	Ammonium Lactate	135	31
Tamsulosin Hcl	Tamsulosin Hcl	135	42
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	129	95
Clotrimazole-Betamethasone	Clotrimazole/Betamethasone Dip	125	46
Diclofenac Sodium	Diclofenac Sodium	122	42
Carvedilol	Carvedilol	116	36
Memantine Hcl	Memantine Hcl	115	42
Finasteride	Finasteride	114	34
Azithromycin	Azithromycin	113	84
Repaglinide	Repaglinide	111	27
Meclizine Hcl	Meclizine Hcl	108	41
Montelukast Sodium	Montelukast Sodium	107	40
Linzess	Linaclotide	105	29
Metoprolol Tartrate	Metoprolol Tartrate	103	34
Nifedipine Er	Nifedipine	98	30
Xarelto	Rivaroxaban	98	18
Allopurinol	Allopurinol	97	29
Simvastatin	Simvastatin	93	28
Meloxicam	Meloxicam	90	45
Ciprofloxacin Hcl	Ciprofloxacin Hcl	85	71
Jardiance	Empagliflozin	84	19
Olmesartan Medoxomil	Olmesartan Medoxomil	76	18
Alendronate Sodium	Alendronate Sodium	75	29
Entresto	Sacubitril/Valsartan	75	16
Donepezil Hcl	Donepezil Hcl	74	28
Folic Acid	Folic Acid	74	28
Enalapril Maleate	Enalapril Maleate	73	23
Methylprednisolone	Methylprednisolone	71	51
Ciclopirox	Ciclopirox	70	24
Sildenafil Citrate	Sildenafil Citrate	70	16
Latanoprost	Latanoprost	68	16
Glipizide	Glipizide	67	25
Easy Touch Alcohol Prep Pads	Alcohol Antiseptic Pads	63	33
Ketoconazole	Ketoconazole	61	21
Spironolactone	Spironolactone	61	17
Mupirocin	Mupirocin	60	35
Glipizide Er	Glipizide	54	21
Triamcinolone Acetonide	Triamcinolone Acetonide	52	31
Ezetimibe	Ezetimibe	50	19
Hydralazine Hcl	Hydralazine Hcl	50	14
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	50	13
Myrbetriq	Mirabegron	48	suppressed
Cefuroxime	Cefuroxime Axetil	47	38
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	47	13
Atenolol	Atenolol	46	14
Chlorthalidone	Chlorthalidone	46	17
Januvia	Sitagliptin Phosphate	46	14
Lantus	Insulin Glargine,hum.Rec.Anlog	46	suppressed
Valsartan	Valsartan	43	13
Bumetanide	Bumetanide	42	suppressed
Omega-3 Acid Ethyl Esters	Omega-3 Acid Ethyl Esters	42	15
Ciclopirox	Ciclopirox Olamine	41	suppressed
Ibuprofen	Ibuprofen	39	16
Metronidazole	Metronidazole	39	29
Synthroid	Levothyroxine Sodium	37	14
Levofloxacin	Levofloxacin	36	34
Clonazepam	Clonazepam	34	11
Brilinta	Ticagrelor	33	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	33	11
Doxycycline Hyclate	Doxycycline Hyclate	31	25
Irbesartan	Irbesartan	31	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	31	suppressed
Cyanocobalamin Injection	Cyanocobalamin (Vitamin B-12)	30	17
Nitroglycerin	Nitroglycerin	30	11
Acetic Acid	Acetic Acid	29	21
Esomeprazole Magnesium	Esomeprazole Magnesium	29	suppressed
Janumet	Sitagliptin Phos/Metformin Hcl	29	suppressed
Mounjaro	Tirzepatide	29	suppressed
Trazodone Hcl	Trazodone Hcl	29	14
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	28	suppressed
Hydrocortisone	Hydrocortisone	27	11
Icosapent Ethyl	Icosapent Ethyl	27	21
Pentoxifylline	Pentoxifylline	27	suppressed
Duloxetine Hcl	Duloxetine Hcl	26	suppressed
Pregabalin	Pregabalin	26	suppressed
Amiodarone Hcl	Amiodarone Hcl	25	suppressed
Celecoxib	Celecoxib	25	15
Dapagliflozin	Dapagliflozin Propanediol	25	18
Methocarbamol	Methocarbamol	24	15
Pioglitazone Hcl	Pioglitazone Hcl	24	11
Symbicort	Budesonide/Formoterol Fumarate	24	suppressed
Lactulose	Lactulose	22	suppressed
Dicyclomine Hcl	Dicyclomine Hcl	21	suppressed
Novolog Flexpen	Insulin Aspart	21	suppressed
Ondansetron Hcl	Ondansetron Hcl	21	18
Atrovent Hfa	Ipratropium Bromide	20	suppressed
Glimepiride	Glimepiride	20	suppressed
Nano 2nd Gen Pen Needle	Pen Needle, Diabetic	20	suppressed
Toujeo Solostar	Insulin Glargine,hum.Rec.Anlog	20	suppressed
Brimonidine Tartrate-Timolol	Brimonidine Tartrate/Timolol	19	suppressed
Mirtazapine	Mirtazapine	19	12
Nystatin	Nystatin	19	suppressed
Dorzolamide-Timolol	Dorzolamide Hcl/Timolol Maleat	18	suppressed
Silver Sulfadiazine	Silver Sulfadiazine	18	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	18	18
Amlodipine-Valsartan	Amlodipine Besylate/Valsartan	17	suppressed
Breo Ellipta	Fluticasone/Vilanterol	17	suppressed
Rybelsus	Semaglutide	17	suppressed
Tadalafil	Tadalafil	17	suppressed
Diclofenac Potassium	Diclofenac Potassium	16	suppressed
Sertraline Hcl	Sertraline Hcl	16	suppressed
Ulticare Pen Needle	Pen Needle, Diabetic	16	suppressed
Acyclovir	Acyclovir	15	13
Creon	Lipase/Protease/Amylase	15	suppressed
Erythromycin	Erythromycin Base	15	13
Lansoprazole	Lansoprazole	15	suppressed
Lovastatin	Lovastatin	15	suppressed
Propranolol Hcl	Propranolol Hcl	15	suppressed
Torsemide	Torsemide	15	suppressed
Olmesartan-Hydrochlorothiazide	Olmesartan/Hydrochlorothiazide	14	suppressed
Sucralfate	Sucralfate	14	suppressed
Metoclopramide Hcl	Metoclopramide Hcl	13	suppressed
Pravastatin Sodium	Pravastatin Sodium	13	suppressed
Temazepam	Temazepam	13	suppressed
Benazepril Hcl	Benazepril Hcl	12	suppressed
Bydureon Bcise	Exenatide Microspheres	12	suppressed
Diltiazem Hcl	Diltiazem Hcl	12	suppressed
Fenofibrate	Fenofibrate	12	suppressed
Spiriva Respimat	Tiotropium Bromide	12	suppressed
Tradjenta	Linagliptin	12	suppressed
Tresiba Flextouch U-100	Insulin Degludec	12	suppressed
Ceftriaxone	Ceftriaxone Sodium	11	11
Combivent Respimat	Ipratropium/Albuterol Sulfate	11	suppressed
Dutasteride	Dutasteride	11	suppressed
Easy Touch Pen Needle	Pen Needle, Diabetic	11	suppressed
Mesalamine Er	Mesalamine	11	suppressed
Nitrofurantoin	Nitrofurantoin Macrocrystal	11	suppressed
Synjardy	Empagliflozin/Metformin Hcl	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error